Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chee Leong Cheng
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising From Follicular Lymphoma in Asian Patients Treated in the Rituximab Era
Scientific Reports
Multidisciplinary
Fibro-C-Index: Comprehensive, Morphology-Based Quantification of Liver Fibrosis Using Second Harmonic Generation and Two-Photon Microscopy
Journal of Biomedical Optics
Electronic
Optics
Molecular Physics,
Optical
Biomaterials
Atomic
Magnetic Materials
Biomedical Engineering
Related publications
The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Assessment Index of Clinical Transformation From Follicular Lymphoma (Fl) to Diffuse Large B-Cell Lymphoma (Dlbcl) in the Rituximab Era
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Histologically Transformed Follicular Lymphoma Exhibits Protein Profiles Different From Both Non-Transformed Follicular and De Novo Diffuse Large B-Cell Lymphoma
Blood Cancer Journal
Oncology
Hematology
Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Multicentre Study of Primary Breast Diffuse Large B-Cell Lymphoma in the Rituximab Era
British Journal of Haematology
Hematology
Prognostic Nomogram for Overall Survival in Patients With Diffuse Large B‐Cell Lymphoma
Oncologist
Cancer Research
Medicine
Oncology
Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and CHOP
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Secondary Cutaneous Diffuse Large B-Cell Lymphoma Has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-Cell Lymphoma, Leg Type
Acta Dermato-Venereologica
Dermatology
Medicine
